To demonstrate that an increase of Rab35 levels is a specific feature of PD, we examined the serum level of Rab35 in patients affected with non-parkinsonism CNS diseases, including Alzheimer's disease (AD), spinocerebellar ataxia (SCA) and Huntington's disease (HD). This evidence concerns the gene RAB35 and Parkinson disease.